Anna Chiu
Impact in
-
- Antibiotic Use and Resistance
- Virology top 5%
- HIV Research and Treatment
Papers in
-
- HIV/AIDS drug development and treatment 5
- Antimicrobial Resistance in Staphylococcus 4
- HIV/AIDS Research and Interventions 1
-
- Pharmacogenetics and Drug Metabolism 1
- Drug-Induced Adverse Reactions 1
- Co-authors
- Chaim M. Bell (5 shared papers)Marilyn Steinberg (5 shared papers)Daniel R. Ricciuto (5 shared papers)Lisa D. Burry (5 shared papers)Adrienne Showler (5 shared papers)Andrew Mark Morris (5 shared papers)Anthony D. Bai (5 shared papers)Sumit Raybardhan (5 shared papers)
- Journals
- Molecular Pharmaceutics (1 paper)The Lancet (1 paper)The Journal of Clinical Endocrinology & Metabolism (1 paper)Clinical Infectious Diseases (1 paper)European Journal of Clinical Microbiology & Infectious Diseases (1 paper)
- Partner nations
- CanadaUnited StatesChina
In The Last Decade
Anna Chiu
12 papers receiving 793 citations
Anna Chiu's Hit Papers
Peers
Comparison fields: 5 of 70
- Applied Microbiology and Biotechnology 97
- Virology 116
- Infectious Diseases 436
- Epidemiology 121
- Clinical Biochemistry 13
Countries citing papers authored by Anna Chiu
This map shows the geographic impact of Anna Chiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Chiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Chiu more than expected).
Fields of papers citing papers by Anna Chiu
This network shows the impact of papers produced by Anna Chiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Chiu. The network helps show where Anna Chiu may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Chiu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 329 | |
| 2 | 2015 | 229 | |
| 3 | 2015 | 68 | |
| 4 | 2001 | 40 | |
| 5 | 2023 | 37 | |
| 6 | Pharmacokinetics and safety of once-yearly lenacapavir: a phase 1, open-label study Hit paper breakdown → | 2025 | 32 |
| 7 | 2015 | 28 | |
| 8 | 2017 | 21 | |
| 9 | 2018 | 13 | |
| 10 | 2024 | 10 | |
| 11 | 2015 | 9 | |
| 12 | 2007 | 1 |
About Anna Chiu
Anna Chiu is a scholar working on Infectious Diseases, Pharmacology, Epidemiology, Pharmacology and Endocrinology, Diabetes and Metabolism, having authored 12 papers that have together received 817 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (5 papers), Antimicrobial Resistance in Staphylococcus (4 papers), Infective Endocarditis Diagnosis and Management (2 papers), Pharmacogenetics and Drug Metabolism (1 paper), Sepsis Diagnosis and Treatment (1 paper), HIV/AIDS Research and Interventions (1 paper), Drug-Induced Adverse Reactions (1 paper) and Nutrition and Health in Aging (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (97 citations), Virology (116 citations), Infectious Diseases (436 citations), Epidemiology (121 citations) and Clinical Biochemistry (13 citations). Anna Chiu has collaborated with scholars based in Canada, United States and China. Frequent co-authors include Chaim M. Bell, Marilyn Steinberg, Daniel R. Ricciuto, Lisa D. Burry, Adrienne Showler, Andrew Mark Morris, Anthony D. Bai, Sumit Raybardhan, Eshan Fernando and Michelle E. Science. Their work appears in journals such as Molecular Pharmaceutics, The Lancet, The Journal of Clinical Endocrinology & Metabolism, Clinical Infectious Diseases and European Journal of Clinical Microbiology & Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.